Financial comparisons VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 03:30:31 2025-02-10 pm EST 5-day change 1st Jan Change
2.325 USD -3.53% Intraday chart for VYNE Therapeutics Inc. -1.29% -31.64%
Main competitors
Add to a list
Revenues (N-1) Net margin (N-1) EBIT margin (N-1) ROE (N-1) ROA (N-1) Leverage (N-1)
424K 6,710.38%6,900.47% - - -
9.87B 36.68%44.33%22.99%17.71%-2.46x
14.2B 31.07%36.33%19.23%15.02%-1.12x
1.29B 23.26%33.51%8.54%7.69%10.14x
4.22B 24.36%18.08%4.62%4.02%-13.1x
2.46B 35.86%49.12%22.26%14.47%2.05x
5.69B 26.5%29.43%18.99%15.45%-0.64x
305M 245.59%232.51% - 50.2%-0.8x
1.89B 13.23%13.3%12.68%8.89%-5.76x
2.44B 26.42%32.3%14.78%13.31%-5.01x
2.4B 19.96%24.97%9.02%6.41%-0.78x
1.24B 43.11%21.54%86.15%1.86%1.96x
1.83B 11.35%9.34%8.74%6.91%-5.06x
638M 44.81%45.26%55.36%27.64%0.65x
295M 180.51%170.79%818.43%50.27%-0.33x
50.83M 205.3%166.94%58.43% - 2.98x
Average 3.05B percentage-no-prefix percentage-no-prefix percentage-no-prefix percentage-no-prefix -1.15x
Weighted average by Cap. 6.82B percentage-no-prefix percentage-no-prefix percentage-no-prefix percentage-no-prefix -1.17x
Bio Therapeutic Drugs